Mediastinal Large B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Mediastinal Large B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-11-30Clinical Trial Update: Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma [Phase 2]
Phase 2 clinical trial evaluating rituximab with or without bleomycin sulfate for primary mediastinal large B-cell lymphoma has been withdra…
-
CLINICAL_TRIALS withdrawal · 2017-05-19Clinical Trial Update: Brentuximab Vedotin, Bendamustine, and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma [Phase 2]
The Phase 2 trial of Brentuximab Vedotin, Bendamustine, and Rituximab for relapsed or refractory B-cell non-Hodgkin lymphoma has been withdr…
-
CLINICAL_TRIALS withdrawal · 2016-11-25Clinical Trial Update: Efficacy and Safety Study of MDV9300 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) [Phase 2]
This clinical trial update states that the Phase 2 study of MDV9300 in relapsed or refractory diffuse large B-cell lymphoma has been withdra…